Palestinian Medical and Pharmaceutical Journal (Pal. Med. Pharm. J.)

Metastatic B2 Thymoma in a Patient with Myasthenia Gravis Presenting as a Peri-splenic Mass: A Rare Case Report

Article info

2025-07-17
2025-12-11
2025-12-21
None - None

Keywords

  • case
  • mass;
  • Metastasis;
  • Peri-splenic
  • Report
  • B2
  • thymoma;
  • Gravis;
  • Myasthenia
  • Recurrence;

Abstract

Background: Thymomas are rare epithelial tumors of the thymus. Extra-thoracic metastasis is exceptional and typically involves the liver, bone, or soft tissues. Peri-splenic recurrence is exceedingly rare. Case presentation: A 42-year-old female previously treated for thymoma and pleural metastases presented six years later with a peri-splenic mass. CT-guided core biopsy and immunohistochemistry (p40, Pan-CK, TdT, CD3) confirmed metastatic B2 thymoma. Conclusion: This case highlights an unusual pattern of abdominal recurrence and underscores the value of immunohistochemistry in differentiating thymoma metastasis from lymphoma.

Metastatic B2 Thymoma in a Patient with Myasthenia Gravis Presenting as a Peri-splenic Mass: A Rare Case Report

معلومات المقال

2025-07-17
2025-12-11
2025-12-21
None - None

الكلمات الإفتتاحية

  • case
  • mass;
  • Metastasis;
  • Peri-splenic
  • Report
  • B2
  • thymoma;
  • Gravis;
  • Myasthenia
  • Recurrence;

الملخص

Background: Thymomas are rare epithelial tumors of the thymus. Extra-thoracic metastasis is exceptional and typically involves the liver, bone, or soft tissues. Peri-splenic recurrence is exceedingly rare. Case presentation: A 42-year-old female previously treated for thymoma and pleural metastases presented six years later with a peri-splenic mass. CT-guided core biopsy and immunohistochemistry (p40, Pan-CK, TdT, CD3) confirmed metastatic B2 thymoma. Conclusion: This case highlights an unusual pattern of abdominal recurrence and underscores the value of immunohistochemistry in differentiating thymoma metastasis from lymphoma.

Since 2022

Cite Score (Scopus): 0.8
Time to First Decision: 3 Days
Submission to Acceptance: 45 Days
Acceptance to Publication: 64 Days
Acceptance Rate: 17%
Why should you
Publish With Us?
An-Najah National University
Nablus, Palestine
P.O. Box
7, 707
Fax
(970)(9)2345982
Tel.
(970)(9)2345560
(970)(9)2345113/5/6/7-Ext. 2628
E-mail
[email protected]
EIC
Prof. Waleed Sweileh

The Palestinian Medical and Pharmaceutical Journal (Pal. Med. Pharm. J.) © 2024 by An-Najah University, Nablus, Palestine is licensed under CC BY-NC 4.0

News and Views